Hyperglycemia Increases the Complicated Infection and Mortality Rates During Induction Therapy in Adult Acute Leukemia Patients

Overview

Journal Rev Bras Hematol Hemoter

Publisher Elsevier

Specialty Hematology

Date 2013 Apr 13

PMID 23580883

Citations 10

Authors

Carolina do Nascimento Matias

Vladmir Lima

Heberton Medeiros Teixeira

Fernanda Ribeiro Souto

Vera Magalhaes

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the prevalence of hyperglycemia during induction therapy in adult patients with acute leukemia and its effect on complicated infections and mortality during the first 30 days of treatment.

Methods: An analysis was performed in a retrospective cohort of 280 adult patients aged 18 to 60 years with previously untreated acute leukemia who received induction chemotherapy from January 2000 to December 2009 at the Hemocentro de Pernambuco (HEMOPE), Brazil. Hyperglycemia was defined as the finding of at least one fasting glucose measurement > 100 mg/dL observed one week prior to induction therapy until 30 days after. The association between hyperglycemia and complicated infections, mortality and complete remission was evaluated using the Chi-square or Fisher's exact tests by the Statistical Package for Social Sciences (SPSS) in the R software package version 2.9.0.

Results: One hundred and eighty-eight patients (67.1%) presented hyperglycemia at some moment during induction therapy. Eighty-two patients (29.3%) developed complicated infections. Infection-related mortality during the neutropenia period was 20.7% (58 patients). Mortality from other causes during the first 30 days after induction was 2.8%. Hyperglycemia increased the risk of complicated infections (OR 3.97; 95% confidence interval: 2.08 - 7.57; p-value < 0.001) and death (OR 3.55; 95% confidence interval: 1.77-7.12; p-value < 0.001) but did not increase the risk of fungal infections or decrease the probability of achieving complete remission.

Conclusion: This study demonstrates an association between the presence of hyperglycemia and the development of complicated infections and death in adult patients during induction therapy for acute leukemia.

Citing Articles

Stress hyperglycemia is associated with poor prognosis in critically ill patients with cardiogenic shock.

Tian J, Zhou T, Liu Z, Dong Y, Xu H Front Endocrinol (Lausanne). 2024; 15:1446714.

PMID: 39301321 PMC: 11410614. DOI: 10.3389/fendo.2024.1446714.

An Interpretable Machine Learning Framework for Rare Disease: A Case Study to Stratify Infection Risk in Pediatric Leukemia.

Al-Hussaini I, White B, Varmeziar A, Mehra N, Sanchez M, Lee J J Clin Med. 2024; 13(6).

PMID: 38542012 PMC: 10970787. DOI: 10.3390/jcm13061788.

The association of hyperglycemia with the development of infectious complications in adult Filipino patients with acute lymphoblastic leukemia.

Vaswani P, Bernardo D, Quero A, Cruz M, Bonifacio L Hematol Transfus Cell Ther. 2021; 45(1):66-71.

PMID: 34593366 PMC: 9938473. DOI: 10.1016/j.htct.2021.06.010.

Current cancer therapies and their influence on glucose control.

Yim C, Mansell K, Hussein N, Arnason T World J Diabetes. 2021; 12(7):1010-1025.

PMID: 34326951 PMC: 8311484. DOI: 10.4239/wjd.v12.i7.1010.

Azacitidine-induced hyperglycaemia.

Morton A BMJ Case Rep. 2019; 12(11).

PMID: 31791988 PMC: 6887431. DOI: 10.1136/bcr-2019-231903.

References

Hostetter M . Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990; 39(3):271-5. DOI: 10.2337/diab.39.3.271. View

Mohammedi K, Roussel R, Marre M . Glucose control in critically ill patients. N Engl J Med. 2009; 361(1):90-1. View

Weiser M, Cabanillas M, Konopleva M, Thomas D, Pierce S, Escalante C . Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004; 100(6):1179-85. DOI: 10.1002/cncr.20071. View

Derr R, Hsiao V, Saudek C . Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care. 2008; 31(10):1972-7. PMC: 2551637. DOI: 10.2337/dc08-0574. View

Kavanagh B, McCowen K . Clinical practice. Glycemic control in the ICU. N Engl J Med. 2010; 363(26):2540-6. DOI: 10.1056/NEJMcp1001115. View

Subramaniam B, Panzica P, Novack V, Mahmood F, Matyal R, Mitchell J . Continuous perioperative insulin infusion decreases major cardiovascular events in patients undergoing vascular surgery: a prospective, randomized trial. Anesthesiology. 2009; 110(5):970-7. DOI: 10.1097/ALN.0b013e3181a1005b. View

Pierre K, Jones C, Stain S . Benefits of intense glucose control in critically ill patients. Curr Surg. 2005; 62(3):277-82. DOI: 10.1016/j.cursur.2004.09.014. View

Fahy B, Sheehy A, Coursin D . Glucose control in the intensive care unit. Crit Care Med. 2009; 37(5):1769-76. DOI: 10.1097/CCM.0b013e3181a19ceb. View

Baker E, Janaway C, Philips B, Brennan A, Baines D, Wood D . Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61(4):284-9. PMC: 2104606. DOI: 10.1136/thx.2005.051029. View

10.

Kovalaske M, Gandhi G . ACP Journal Club. Review: Intensive insulin therapy increases risk for hypoglycemia but not mortality in critically ill adults. Ann Intern Med. 2009; 151(4):JC2-4, JC2-5. DOI: 10.7326/0003-4819-151-4-200908180-02004. View

11.

Hirsch I . In-patient hyperglycemia--are we ready to treat it yet?. J Clin Endocrinol Metab. 2002; 87(3):975-7. DOI: 10.1210/jcem.87.3.8401. View

12.

Cook D, McIntyre L . Intensive insulin therapy and starch (HES 200/0.5) had some risk and no clear benefit in severe sepsis. ACP J Club. 2008; 148(4):4. DOI: 10.7326/0003-4819-148-12-200806170-02004. View

13.

Bagshaw S, Hoste E, Jacka M . Best evidence in critical care medicine. Intensive vs conventional blood glucose control in critically ill patients. Can J Anaesth. 2010; 57(2):172-5. DOI: 10.1007/s12630-009-9225-4. View

14.

Brunkhorst F, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N . Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358(2):125-39. DOI: 10.1056/NEJMoa070716. View

15.

Hurley D, McMahon M . Intensive insulin therapy reduced mortality and morbidity in critically ill patients. ACP J Club. 2002; 136(3):81. DOI: 10.7326/acpjc-2002-136-3-081. View

16.

Satchie B, Kudsk K . Utility of intensive blood glucose control: generalizable to all general surgery patients?. Nutr Clin Pract. 2005; 19(2):181-3. DOI: 10.1177/0115426504019002181. View

17.

Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M . Intensive insulin therapy in critically ill patients. N Engl J Med. 2002; 345(19):1359-67. DOI: 10.1056/NEJMoa011300. View

18.

Preiser J, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J . A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009; 35(10):1738-48. DOI: 10.1007/s00134-009-1585-2. View

19.

Buyukcelik A, Yalcin B, Utkan G, Doruk H . Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. Cancer. 2004; 101(5):1100-1. DOI: 10.1002/cncr.20461. View

20.

Hurt R, McClave S, Azeem N, Cole S, Wetzel D, Khambatta S . Understanding the clinical issues involved with glycemic control in the intensive care unit. Curr Gastroenterol Rep. 2011; 13(4):301-5. DOI: 10.1007/s11894-011-0200-1. View